Concepedia

Daniel S. Kong

DS

Statistics

Publications

12

Citations

795

H-Index

11

Active since

2009

Affiliations

University of Hong Kong(Current)

University of Colorado Denver

Children's Hospital Colorado

Queen Mary Hospital

The University of Texas MD Anderson Cancer Center

Daniel S. Kong is an author at University of Hong Kong specializing in medicine, oncology, and molecular oncology.

Publications per year

2009–2023

12

Publications

12

p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients

Michelle K.Y. Siu, Hoi Yan Chan, Daniel S. Kong et al. · Proceedings of the National Academy of Sciences · 2010 · 177 citations · Full text

, , +17

Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers

Michelle K.Y. Siu, Emma Wong, Daniel S. Kong et al. · Oncogene · 2012 · 167 citations

, , +15

Paradoxical Impact of Two Folate Receptors, FRα and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome

Michelle K.Y. Siu, Daniel S. Kong, Hoi Yan Chan et al. · PLoS ONE · 2012 · 103 citations · Full text

, , +16

A novel human <i>IL2RB</i> mutation results in T and NK cell–driven immune dysregulation

Isabel Z. Fernandez, Ryan M. Baxter, Josselyn E. Garcia‐Perez et al. · The Journal of Experimental Medicine · 2019 · 94 citations · Full text

, , +17

Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion

Michelle K.Y. Siu, Esther S.Y. Wong, Daniel S. Kong et al. · International Journal of Cancer · 2009 · 89 citations · Full text

, , +17

1–5 of 12